GW Pharmaceuticals to Present at the Cowen and Company 37th …

LONDON, March 02, 2017 — GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announced that Justin Gover, GW’s Chief Executive Officer, will present at the Cowen and Company 37th Annual Healthcare Conference on Wednesday, 8 March, 2017 at 8:40 a.m. EST at the Boston Marriott Copley Place, Boston.  

A live audio webcast of the presentation will be available through GW’s corporate website at www.gwpharm.com on the Investors section under Events Presentations. A replay will be available soon after the live presentation.

About GW Pharmaceuticals plc

Founded in 1998, GW is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. GW is advancing an orphan drug program in the

... read more at: http://www.econotimes.com/GW-Pharmaceuticals-to-Present-at-the-Cowen-and-Company-37th-Annual-Healthcare-Conference-on-Wednesday-8-March-2017-570389